Drug Type Allergen extract |
Synonyms Mannan-conjugated allergoids of birch pollen allergens, T 502 |
Target- |
Mechanism Immunomodulators |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhasePendingPhase 3 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Allergic rhinoconjunctivitis | Phase 3 | DE | 16 Nov 2021 | |
Rhinitis, Allergic | Phase 3 | DE | 04 Oct 2021 |